Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
22.52
+0.33 (1.49%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$2,716,762
Profits / Employee
$905,464
Market Cap
2.74B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CPRX News
- 10 days ago - Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals - GlobeNewsWire
- 23 days ago - Strong Revenue, Drug Performance Lift Catalyst Shares - FXEmpire
- 5 weeks ago - Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts - Seeking Alpha
- 6 weeks ago - Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges - Seeking Alpha
- 7 weeks ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 - GlobeNewsWire